Hematology | Clinical

Clinical Trials of Lenvatinib Combination Therapy

July 20, 2021

A thought leader in the management of hepatocellular carcinoma provides an overview of several clinical trials of combination therapy with lenvatinib including studies of real-world evidence and potential biomarkers.

First Patient Dosed in LAVA-051 Hematologic Malignancy Trial

July 19, 2021

The first patient has been dosed in the phase 1/2a clinical trial, designed to evaluate LAVA-051- a gamma-delta bispecific gamma-delta T cell engager that activates Vγ9Vδ2 T cells and type 1 natural killer T cells-in those with chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia.

Clinical Trial Matching Service in Hematologic Cancers Mitigates Barriers to Enrollment

July 18, 2021

A national, telephone-based nurse navigator-led service model that aimed to reduce barriers to clinical trial participation among patients with a blood cancer and identified patient demographic and clinical characteristics associated with enrollment was shown to mitigate modifiable barriers to trial enrollment.